238 related articles for article (PubMed ID: 15571851)
1. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
[TBL] [Abstract][Full Text] [Related]
2. Costs associated with hospital-acquired bacteraemia in an Indian hospital: a case-control study.
Kothari A; Sagar V; Ahluwalia V; Pillai BS; Madan M
J Hosp Infect; 2009 Feb; 71(2):143-8. PubMed ID: 19058876
[TBL] [Abstract][Full Text] [Related]
3. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
4. Financial consequences of hospital-acquired bacteraemia in three Belgian hospitals in 2003 and 2004.
Pirson M; Leclercq P; Jackson T; Leclercq M; Garrino M; Sion C
J Hosp Infect; 2008 Jan; 68(1):9-16. PubMed ID: 18055065
[TBL] [Abstract][Full Text] [Related]
5. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed.
Plowman R; Graves N; Griffin MA; Roberts JA; Swan AV; Cookson B; Taylor L
J Hosp Infect; 2001 Mar; 47(3):198-209. PubMed ID: 11247680
[TBL] [Abstract][Full Text] [Related]
6. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
[TBL] [Abstract][Full Text] [Related]
7. Problems and solutions in hospital-acquired bacteraemia.
Correa L; Pittet D
J Hosp Infect; 2000 Oct; 46(2):89-95. PubMed ID: 11049700
[TBL] [Abstract][Full Text] [Related]
8. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
[TBL] [Abstract][Full Text] [Related]
9. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
[TBL] [Abstract][Full Text] [Related]
10. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
11. Economics of central line--associated bloodstream infections.
Shannon RP; Patel B; Cummins D; Shannon AH; Ganguli G; Lu Y
Am J Med Qual; 2006; 21(6 Suppl):7S-16S. PubMed ID: 17077414
[TBL] [Abstract][Full Text] [Related]
12. Prospective casemix-based funding, analysis and financial impact of cost outliers in all-patient refined diagnosis related groups in three Belgian general hospitals.
Pirson M; Martins D; Jackson T; Dramaix M; Leclercq P
Eur J Health Econ; 2006 Mar; 7(1):55-65. PubMed ID: 16416135
[TBL] [Abstract][Full Text] [Related]
13. [Hospital-acquired bacteraemia and fungaemia. A regional study with national implications].
Schønheyder HC; Søgaard M
Ugeskr Laeger; 2007 Nov; 169(48):4175-9. PubMed ID: 18211787
[TBL] [Abstract][Full Text] [Related]
14. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
[TBL] [Abstract][Full Text] [Related]
15. A cost-minimisation study of alternative discharge policies after hip fracture repair.
Polder JJ; van Balen R; Steyerberg EW; Cools HJ; Habbema JD
Health Econ; 2003 Feb; 12(2):87-100. PubMed ID: 12563657
[TBL] [Abstract][Full Text] [Related]
16. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey.
Coskun D; Aytac J; Aydinli A; Bayer A
J Hosp Infect; 2005 Jun; 60(2):176-9. PubMed ID: 15866018
[TBL] [Abstract][Full Text] [Related]
17. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
18. The excess cost associated with healthcare-associated bloodstream infections at Auckland City Hospital.
Burns A; Bowers L; Pak NT; Wignall J; Roberts S
N Z Med J; 2010 Oct; 123(1324):17-24. PubMed ID: 20953218
[TBL] [Abstract][Full Text] [Related]
19. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
Orsi GB; Di Stefano L; Noah N
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
[TBL] [Abstract][Full Text] [Related]
20. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs.
Vrijens F; Hulstaert F; Devriese S; van de Sande S
Epidemiol Infect; 2012 Jan; 140(1):126-36. PubMed ID: 21320376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
